The soluble form of Fas molecule is elevated in parkinsonian brain tissues

Neuroscience Letters

Volumn 220, Issue 3, 1996, Pages 195-198

  Mogi, Makio ^a   Harada, Minoru ^a   Kondo, Tomoyoshi ^b   Mizuno, Yoshikuni ^b   Narabayashi, Hirotaro ^b   Riederer, Peter ^c   Nagatsu, Toshiharu ^d  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain; Fas; Parkinson's disease

Indexed keywords

CELL SURFACE RECEPTOR;

APOPTOSIS; ARTICLE; BRAIN REGION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NERVE DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTIGENS, CD95; BRAIN CHEMISTRY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; UP-REGULATION;

EID: 0030595986     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)13257-2     Document Type: Article

References (24)

1. [1] Abreu-Martin, M.T., Vidrich, A., Lynch, D.H. and Targan, S.R., Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-α and ligation of Fas antigen, J. Immunol., 155 (1995) 4147-4154.
2. [2] Afford, S.C., Pongracz, J., Stockley, R.A., Crocker, J. and Burnett, D., The induction by human interleukin-6 of apoptosis in the promonocytic cell line U937 and human neutrophils, J. Biol. Chem., 267 (1992) 21612-21616.
3. [3] Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal. Biochem., 72 (1976) 248-254.
4. [4] Burakoff, S.J., Engelhard, V.H., Kaufman, J. and Strominger, J.L., Induction of secondary cytotoxic T lymphocytes by liposomes containing HLA-DR antigens, Nature, 283 (1980) 495-497.
5. [5] Cheng, J., Zhou, T., Liu, C., Shapiro, J.P., Brauer, M.J., Kiefer, M.C., Barr, P.J. and Mountz, J.D., Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule, Science, 263 (1994) 1759-1762.
6. [6] Dipasquale, B., Marini, A.M. and Youle, R.J., Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons, Biochem. Biophys. Res. Commun., 181 (1991) 1442-1448.
7. [7] Fiszer, U., Piotrowska, K., Korlak, J. and Czlonkowska, A., The immunological status in Parkinson's disease, Med. Lab. Sci., 48 (1991) 196-200.
8. [8] Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y. and Nagata, S., The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell, 66 (1991) 233-243.
9. [9] Itoh, N., Tsujimoto, Y. and Nagata, S., Effect of bcl-2 on Fas antigen-mediated cell death, J. Immunol., 151 (1993) 621-627.
10. [10] Lenardo, M.J., Interleukin-2 programs mouse αβ T lymphocytes for apoptosis, Nature, 353 (1991) 858-861.
11. [11] Knipping, E., Debatin, K.-M., Stricker, K., Heilig, B., Eder, A. and Krammer, P.H., Identification of soluble APO-1 in supernatants of human B-and T-cell lines and increased serum levels in B-and T-cell leukemias, Blood, 85 (1995) 1562-1569.
12. [12] Matsuyama, T., Hata, R., Tagaya, M., Yamamoto, Y., Nakajima, T., Furuyama, J., Wanaka, A. and Sugita, M., Fas antigen mRNA induction in postischemic murine brain. Brain Res., 657 (1994) 342-346.
13. [13] Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K. and Nagatsu, T., Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients, Neurosci. Lett., 165 (1994) 208-210.
14. [14] Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M. and Nagatsu, T., Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients, Neurosci. Lett., 180 (1994) 147-150.
15. 2-microglobulin levels are elevated in the striatum in Parkinson's disease, J. Neural Trans. (P.-D. Sect), 9 (1995) 87-92.
16. [16] Mogi, M., Harada, M., Kondo, T., Narabayashi, H., Riederer, P. and Nagatsu, T., Transforming growth factor-β1 levels are elevated inthe striatum and in ventricular cerebrospinal fluid in Parkinson's disease, Neurosci. Lett., 193 (1995) 129-132.
17. [17] Mogi, M., Harada, M., Kondo, T., Mizuno, Y., Narabayashi, H., Riederer, P. and Nagatsu, T., bcl-2 Protein is increased in the brain from parkinsonian patients, Neurosci. Lett., 215 (1996) 137-139.
18. [18] Moller, P., Henne, C., Leithauser, F., Eichelmann, A., Schmidt, A., Bruderlein, S., Dhein, J. and Krammer, P.H., Coregulation of the APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B-cell lymphomas, Blood, 81 (1993) 2067-2075.
19. [19] Nagata, S. and Golstein, P., The Fas death factor, Science, 267 (1995) 1449-1456.
20. [20] Selmaj, K.W., Farooq, M., Norton, W.T., Raine, C.S. and Brosnan, C.F., Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor, J. Immunol., 144 (1990) 129-135.
21. [21] Watanabe-Fukunaga, R., Brannan, C.I., Itoh, N., Yonehara, S., Copeland, N.G., Jenkins, N.A. and Nagata, S., The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen, J. Immunol., 148 (1992) 1274-1279.
22. [22] Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A. and Nagata, S., Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis, Nature, 356 (1992) 314-317.
23. [23] Wood, J.A., Wood, P.L., Ryan, R., Graff-Radford, N.R., Pilapil, C., Robitaille, Y. and Quirion, R., Cytokine induces in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein, Brain Res., 629 (1993) 245-252.
24. [24] Yonehara, S., Ishii, A. and Yonehara, M., A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor, J. Exp. Med., 169 (1989) 1747-1756.